Molecular diagnostics have evolved in recent years as an alternative to traditional diagnostic methods such as virus/bacteria culture, microscopy, histopathology-based techniques (ie immunohistochemistry and in situ hybridisation), biochemical, phenotypic or serological analysis. These molecular methods are based on the amplification of a region of the target nucleic acid (either DNA or RNA) and are becoming increasingly popular with end-users.
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $20 billion and more than 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics...
Learn more »
The Atrium Conference Centre, Sheffield Hallam University
5-6 June 2019
Bearsted Lecture Theatre, Alexandra Wing, Queen Mary University of London - Whitechapel
26-27 June 2019
St Edmund Hall, Queen's Lane, Oxford OX1 4AR
9-11 September 2019
22-25 September 2019
Reducing exposure to antimicrobial agents
Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.
Don't miss out on the latest news affecting UK Pathology Services, Biomedical Scientists and Medical Laboratory Professionals. Register FREE for your regular copy of Pathology In Practice now, and enjoy FREE access to feature article content and to the digital version of Pathology In Practice along with regular news delivered to your inbox.